Cargando…
Clinical potential of TCF21 methylation in the diagnosis of renal cell carcinoma
The aim of the present study was to investigate the clinical potential of transcription factor (TCF) 21 methylation in the diagnosis of renal cell carcinoma (RCC). TCF21 methylation levels were quantified in renal tissues (55 cases of RCC tissue and 22 cases of normal tissue) and urine samples (33 c...
Autores principales: | Xin, Jun, Xu, Rong, Lin, Shaokun, Xin, Minghua, Cai, Wenjie, Zhou, Jin, Fu, Changde, Zhen, Guangfu, Lai, Jinjin, Li, Yue, Zhang, Pengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950740/ https://www.ncbi.nlm.nih.gov/pubmed/27446425 http://dx.doi.org/10.3892/ol.2016.4748 |
Ejemplares similares
-
CircHIPK3 promotes proliferation and metastasis and inhibits apoptosis of renal cancer cells by inhibiting MiR-485-3p
por: Lai, Jinjin, et al.
Publicado: (2020) -
TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration
por: Gooskens, Saskia L., et al.
Publicado: (2017) -
CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity
por: Dong, Zhao-Ru, et al.
Publicado: (2021) -
Upregulation of TCF21 inhibits migration of adrenocortical carcinoma cells
por: Kremer, Jean Lucas, et al.
Publicado: (2021) -
Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma
por: Chen, Yue, et al.
Publicado: (2018)